{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:21:35Z","timestamp":1772119295807,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-022-05134-z","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T03:02:53Z","timestamp":1651201373000},"page":"1797-1806","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tuberculin skin test before biologic and targeted therapies: does the same rule apply for all?"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6443-6426","authenticated-orcid":false,"given":"Ufuk","family":"\u0130lgen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3443-3117","authenticated-orcid":false,"given":"\u00d6mer","family":"Karada\u011f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5184-4404","authenticated-orcid":false,"given":"Hakan","family":"Emmungil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4530-2304","authenticated-orcid":false,"given":"Orhan","family":"K\u00fc\u00e7\u00fck\u015fahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4995-430X","authenticated-orcid":false,"given":"S\u00fcleyman Serdar","family":"Koca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8084-2018","authenticated-orcid":false,"given":"Abd\u00fclsamet","family":"Erden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1730-2991","authenticated-orcid":false,"given":"Cemal","family":"Bes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1185-5816","authenticated-orcid":false,"given":"Nil\u00fcfer","family":"Alpay Kan\u0131tez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8645-2670","authenticated-orcid":false,"given":"Ediz","family":"Dalk\u0131l\u0131\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3734-1242","authenticated-orcid":false,"given":"Servet","family":"Akar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1537-2192","authenticated-orcid":false,"given":"R\u0131dvan","family":"Mercan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6150-3539","authenticated-orcid":false,"given":"Muhammet","family":"\u00c7\u0131nar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9941-5884","authenticated-orcid":false,"given":"Timu\u00e7in","family":"Ka\u015fifo\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6990-4206","authenticated-orcid":false,"given":"Emel","family":"G\u00f6n\u00fcll\u00fc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3775-639X","authenticated-orcid":false,"given":"Gezmi\u015f","family":"Kimyon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6172-7762","authenticated-orcid":false,"given":"Duygu","family":"Ers\u00f6zl\u00fc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6393-7461","authenticated-orcid":false,"given":"Pamir","family":"Atag\u00fcnd\u00fcz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3102-5847","authenticated-orcid":false,"given":"Levent","family":"K\u0131l\u0131\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3904-0769","authenticated-orcid":false,"given":"\u0130hsan","family":"Ertenli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3176-4850","authenticated-orcid":false,"given":"Veli","family":"Yaz\u0131s\u0131z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1966-3333","authenticated-orcid":false,"given":"A\u015fk\u0131n","family":"Ate\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2802-6061","authenticated-orcid":false,"given":"Sedat","family":"Kiraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7129-2109","authenticated-orcid":false,"given":"Umut","family":"Kalyoncu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"key":"5134_CR1","unstructured":"World Health Organization (2018) Latent tuberculosis infection\u2014Updated and consolidated guidelines for programmatic management. https:\/\/apps.who.int\/iris\/handle\/10665\/260233 Accessed 3 April 2022"},{"key":"5134_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3899\/jrheum.140101","volume":"91","author":"F Iannone","year":"2014","unstructured":"Iannone F, Cantini F, Lapadula G (2014) Diagnosis of latent tuberculosis and prevention of reactivation in rheumatic patients receiving biologic therapy: international recommendations. J Rheumatol Suppl 91:41\u201346. https:\/\/doi.org\/10.3899\/jrheum.140101","journal-title":"J Rheumatol Suppl"},{"key":"5134_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.39480","volume":"68","author":"JA Singh","year":"2016","unstructured":"Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC et al (2016) 2015 American college of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 68:1\u201326. https:\/\/doi.org\/10.1002\/art.39480","journal-title":"Arthritis Rheumatol"},{"key":"5134_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10165-007-0626-3","volume":"17","author":"R Koike","year":"2007","unstructured":"Koike R, Takeuchi T, Eguchi K, Miyasaka N, College J, of Rheumatology, (2007) Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis. Mod Rheumatol 17:451\u2013458. https:\/\/doi.org\/10.1007\/s10165-007-0626-3","journal-title":"Mod Rheumatol"},{"key":"5134_CR5","unstructured":"Australian Rheumatology Association (2018) Screening for Latent Tuberculosis Infection (LTBI) and its management in Inflammatory arthritis patients. https:\/\/rheumatology.org.au\/Portals\/2\/Documents\/Public\/Professionals\/SCREENINGFORLATENTTUBERCULOSISINFECTION_Jan18.pdf?ver=2021-06-28-141621-710 Accessed 3 April 2022"},{"key":"5134_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4081\/reumatismo.2019.1202","volume":"71","author":"S Parisi","year":"2019","unstructured":"Parisi S, Bortoluzzi A, Sebastiani GD, Conti F, Caporali R, Ughi N et al (2019) The Italian society for rheumatology clinical practice guidelines for rheumatoid arthritis. Reumatismo 71:22\u201349. https:\/\/doi.org\/10.4081\/reumatismo.2019.1202","journal-title":"Reumatismo"},{"key":"5134_CR7","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.3899\/jrheum.120165","volume":"39","author":"C Bombardier","year":"2012","unstructured":"Bombardier C, Hazlewood GS, Akhavan P, Schieir O, Dooley A, Haraoui B et al (2012) Canadian rheumatology association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs: part II safety. J Rheumatol 39:1583\u20131602. https:\/\/doi.org\/10.3899\/jrheum.120165","journal-title":"J Rheumatol"},{"key":"5134_CR8","unstructured":"T.C. Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 T\u00fcrkiye Halk Sa\u011fl\u0131\u011f\u0131 Kurumu (2016) Anti-TNF kullanan hastalarda t\u00fcberk\u00fcloz rehberi. [Turkish] http:\/\/www.romatoloji.org\/Dokumanlar\/Site\/ATKHTR.pdf Accessed 3 April 2022"},{"key":"5134_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/cid\/ciw778","volume":"64","author":"DM Lewinsohn","year":"2017","unstructured":"Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E et al (2017) Official American thoracic society\/infectious diseases society of america\/centers for disease control and prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis 64:111\u2013115. https:\/\/doi.org\/10.1093\/cid\/ciw778","journal-title":"Clin Infect Dis"},{"key":"5134_CR10","doi-asserted-by":"publisher","unstructured":"2000 Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 161: S221 S247 https:\/\/doi.org\/10.1164\/ajrccm.161.supplement_3.ats600.","DOI":"10.1164\/ajrccm.161.supplement_3.ats600"},{"key":"5134_CR11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1086\/338149","volume":"34","author":"E Lee","year":"2002","unstructured":"Lee E, Holzman RS (2002) Evolution and current use of the tuberculin test. Clin Infect Dis 34:365\u2013370. https:\/\/doi.org\/10.1086\/338149","journal-title":"Clin Infect Dis"},{"key":"5134_CR12","first-page":"1","volume":"59","author":"GH Mazurek","year":"2010","unstructured":"Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K, IGRA Expert Committee; Centers for Disease Control and Prevention (CDC) (2010) Updated guidelines for using Interferon gamma release assays to detect Mycobacterium tuberculosis infection\u2014United States, 2010. MMWR Recomm Rep 59:1\u201325","journal-title":"MMWR Recomm Rep"},{"key":"5134_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017984","volume":"6","author":"H Mahomed","year":"2011","unstructured":"Mahomed H, Hawkridge T, Verver S, Abrahams D, Geiter L, Hatherill M et al (2011) The tuberculin skin test versus QuantiFERON TB Gold\u00ae in predicting tuberculosis disease in an adolescent cohort study in South Africa. PLoS ONE 6:e17984. https:\/\/doi.org\/10.1371\/journal.pone.0017984","journal-title":"PLoS ONE"},{"key":"5134_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169539","volume":"12","author":"SK Sharma","year":"2017","unstructured":"Sharma SK, Vashishtha R, Chauhan LS, Sreenivas V, Seth D (2017) Comparison of TST and IGRA in diagnosis of latent tuberculosis infection in a high TB-burden setting. PLoS ONE 12:e0169539. https:\/\/doi.org\/10.1371\/journal.pone.0169539","journal-title":"PLoS ONE"},{"key":"5134_CR15","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1183\/09031936.00153408","volume":"33","author":"B Kampmann","year":"2009","unstructured":"Kampmann B, Whittaker E, Williams A, Walters S, Gordon A, Martinez-Alier N et al (2009) Interferon-gamma release assays do not identify more children with active tuberculosis than the tuberculin skin test. Eur Respir J 33:1374\u20131382. https:\/\/doi.org\/10.1183\/09031936.00153408","journal-title":"Eur Respir J"},{"key":"5134_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1164\/rccm.200402-232OC","volume":"170","author":"I Brock","year":"2004","unstructured":"Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P (2004) Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med 170:65\u201369. https:\/\/doi.org\/10.1164\/rccm.200402-232OC","journal-title":"Am J Respir Crit Care Med"},{"key":"5134_CR17","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1164\/rccm.200608-1099OC","volume":"175","author":"SM Arend","year":"2007","unstructured":"Arend SM, Thijsen SF, Leyten EM, Bouwman JJ, Franken WP, Koster BF et al (2007) Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 175:618\u2013627. https:\/\/doi.org\/10.1164\/rccm.200608-1099OC","journal-title":"Am J Respir Crit Care Med"},{"key":"5134_CR18","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1378\/chest.08-2048","volume":"135","author":"R Diel","year":"2009","unstructured":"Diel R, Loddenkemper R, Meywald-Walter K, Gottschalk R, Nienhaus A (2009) Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube assay, and T-Spot.TB test in contact investigations for tuberculosis. Chest 135:1010\u20131018. https:\/\/doi.org\/10.1378\/chest.08-2048","journal-title":"Chest"},{"key":"5134_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000183","volume":"2","author":"PC Hill","year":"2007","unstructured":"Hill PC, Jeffries DJ, Brookes RH, Fox A, Jackson-Sillah D, Lugos MD et al (2007) Using ELISPOT to expose false positive skin test conversion in tuberculosis contacts. PLoS ONE 2:e183. https:\/\/doi.org\/10.1371\/journal.pone.0000183","journal-title":"PLoS ONE"},{"key":"5134_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.advms.2017","volume":"63","author":"S Erol","year":"2018","unstructured":"Erol S, Ciftci FA, Ciledag A, Kaya A, Kumbasar OO (2018) Do higher cut-off values for tuberculin skin test increase the specificity and diagnostic agreement with interferon gamma release assays in immunocompromised Bacillus Calmette-Gu\u00e9rin vaccinated patients? Adv Med Sci 63:237\u2013241. https:\/\/doi.org\/10.1016\/j.advms.2017","journal-title":"Adv Med Sci"},{"key":"5134_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198756","volume":"13","author":"DH Jeong","year":"2018","unstructured":"Jeong DH, Kang J, Jung YJ, Yoo B, Lee CK, Kim YG et al (2018) Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA. PLoS ONE 13:e0198756. https:\/\/doi.org\/10.1371\/journal.pone.0198756","journal-title":"PLoS ONE"},{"key":"5134_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/1471-2334-9-207","volume":"9","author":"EY Kim","year":"2009","unstructured":"Kim EY, Lim JE, Jung JY, Son JY, Lee KJ, Yoon YW et al (2009) Performance of the tuberculin skin test and interferon-gamma release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population. BMC Infect Dis 9:207. https:\/\/doi.org\/10.1186\/1471-2334-9-207","journal-title":"BMC Infect Dis"},{"key":"5134_CR23","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1007\/s00296-011-2243-x","volume":"32","author":"I Hanta","year":"2012","unstructured":"Hanta I, Ozbek S, Kuleci S, Seydaoglu G, Ozyilmaz E (2012) Detection of latent tuberculosis infection in rheumatologic diseases before anti-TNF\u03b1 therapy: tuberculin skin test versus IFN-\u03b3 assay. Rheumatol Int 32:3599\u20133603. https:\/\/doi.org\/10.1007\/s00296-011-2243-x","journal-title":"Rheumatol Int"},{"key":"5134_CR24","doi-asserted-by":"publisher","first-page":"467","DOI":"10.15403\/jgld.2014.1121.244.bcg","volume":"24","author":"Z Kurti","year":"2015","unstructured":"Kurti Z, Lovasz BD, Gecse KB, Balint A, Farkas K, Morocza-Szabo A et al (2015) Tuberculin skin test and quantiferon in BCG vaccinated, \u0131mmunosuppressed patients with moderate-to-severe \u0131nflammatory bowel disease. J Gastrointest Liver Dis 24:467\u2013472. https:\/\/doi.org\/10.15403\/jgld.2014.1121.244.bcg","journal-title":"J Gastrointest Liver Dis"},{"key":"5134_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2016.10","volume":"5","author":"JW Ai","year":"2016","unstructured":"Ai JW, Ruan QL, Liu QH, Zhang WH (2016) Updates on the risk factors for latent tuberculosis reactivation and their managements. Emerg Microbes Infect 5:e10. https:\/\/doi.org\/10.1038\/emi.2016.10","journal-title":"Emerg Microbes Infect"},{"key":"5134_CR26","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1002\/art.41042","volume":"71","author":"MM Ward","year":"2019","unstructured":"Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA et al (2019) 2019 Update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol 71:1599\u20131613. https:\/\/doi.org\/10.1002\/art.41042","journal-title":"Arthritis Rheumatol"},{"key":"5134_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/acr.23789","volume":"71","author":"JA Singh","year":"2019","unstructured":"Singh JA, Guyatt G, Ogdie A, Gladman DD, Deal C, Deodhar A et al (2019) 2018 American College of Rheumatology\/National psoriasis foundation guideline for the treatment of psoriatic arthritis. Arthritis Care Res (Hoboken) 71:2\u201329. https:\/\/doi.org\/10.1002\/acr.23789","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"5134_CR28","first-page":"991","volume":"35","author":"A Marchesoni","year":"2017","unstructured":"Marchesoni A, Olivieri I, Salvarani C, Pipitone N, D\u2019Angelo S, Mathieu A et al (2017) Recommendations for the use of biologics and other novel drugs in the treatment of psoriatic arthritis: 2017 update from the Italian society of rheumatology. Clin Exp Rheumatol 35:991\u20131010","journal-title":"Clin Exp Rheumatol"},{"key":"5134_CR29","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3906\/sag-1807-200","volume":"48","author":"U Kalyoncu","year":"2018","unstructured":"Kalyoncu U, Ta\u015fc\u0131lar EK, Ertenli A\u0130, Dalk\u0131l\u0131\u00e7 HE, Bes C, K\u00fc\u00e7\u00fck\u015fahin O et al (2018) Methodology of a new inflammatory arthritis registry: treasure. Turk J Med Sci 48:856\u2013861. https:\/\/doi.org\/10.3906\/sag-1807-200","journal-title":"Turk J Med Sci"},{"key":"5134_CR30","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovitz J, Felson DT, Bingham CO 3rd et al (2010) 2010 Rheumatoid arthritis classification criteria: an American college of rheumatology\/European league against rheumatism collaborative initiative. Arthritis Rheum 62:2569\u20132581. https:\/\/doi.org\/10.1002\/art.27584","journal-title":"Arthritis Rheum"},{"key":"5134_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/ard.2010.133645","volume":"70","author":"M Rudwaleit","year":"2011","unstructured":"Rudwaleit M, van der Heijde D, Landewe R, Akkoc N, Brandt J, Chou CT et al (2011) The assessment of spondyloarthritis international society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70:25\u201331. https:\/\/doi.org\/10.1136\/ard.2010.133645","journal-title":"Ann Rheum Dis"},{"key":"5134_CR32","unstructured":"T.C. Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131. T\u00fcberk\u00fcloz Tan\u0131 ve Tedavi Rehberi (2019) [Turkish] https:\/\/hsgm.saglik.gov.tr\/depo\/birimler\/tuberkuloz_db\/haberler\/Tuberkuloz_Tani_Ve_Tedavi_Rehberi_\/Tuberkuloz_Tani_ve_Tedavi_Rehberi_08.07.2019_Yuksek_KB.pdf Accessed 3 April 2022"},{"key":"5134_CR33","first-page":"25","volume":"1","author":"ES U\u00e7an","year":"2000","unstructured":"U\u00e7an ES, Sevin\u00e7 C, Abado\u011flu \u00d6, Arpaz S, Ellidokuz H (2000) Interpretation of tuberculin skin tests, country standards and new requirements. Toraks 1:25\u201329","journal-title":"Toraks"},{"key":"5134_CR34","first-page":"39","volume":"53","author":"E Bozkanat","year":"2005","unstructured":"Bozkanat E, \u00c7ift\u00e7i F, Apayd\u0131n M, Kartalo\u011flu Z, Tozkoparan E, Deniz \u00d6 et al (2005) \u0130stanbul il merkezindeki bir askeri okulda t\u00fcberk\u00fclin cilt testi taramas\u0131. T\u00fcberk Toraks 53:39\u201349","journal-title":"T\u00fcberk Toraks"},{"key":"5134_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5152\/kd.2020.04","volume":"33","author":"A \u0130mre","year":"2020","unstructured":"\u0130mre A, Arslan-G\u00fclen T, Ko\u00e7ak M, Ba\u015f-\u015earahman E, Kayaba\u015f \u00dc (2020) Examination of tuberculin skin test results of health care workers in a hospital and healthy individuals who are not in risk of tuberculosis. Klimik Derg 33:19\u201323","journal-title":"Klimik Derg"},{"key":"5134_CR36","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3906\/sag-1008-1030","volume":"41","author":"F Kazanc\u0131","year":"2011","unstructured":"Kazanc\u0131 F, G\u00fcler E, Da\u011fl\u0131 CE, Garipard\u0131\u00e7 M, Davuto\u011flu M, \u0130spiro\u011flu E et al (2011) The prevalence of tuberculin skin test positivity and the effect of BCG vaccinations on tuberculin induration size in the eastern Mediterranean region of Turkey. Turk J Med Sci 41:711\u2013718. https:\/\/doi.org\/10.3906\/sag-1008-1030","journal-title":"Turk J Med Sci"},{"key":"5134_CR37","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/BF02602749","volume":"10","author":"DN Rose","year":"1995","unstructured":"Rose DN, Schechter CB, Adler JJ (1995) Interpretation of the tuberculin skin test. J Gen Intern Med 10:635\u2013642. https:\/\/doi.org\/10.1007\/BF02602749","journal-title":"J Gen Intern Med"},{"key":"5134_CR38","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1136\/thoraxjnl-2015-207811","volume":"71","author":"SH Wong","year":"2016","unstructured":"Wong SH, Gao Q, Tsoi KK, Wu WK, Tam LS, Lee N et al (2016) Effect of immunosuppressive therapy on interferon \u03b3 release assay for latent tuberculosis screening in patients with autoimmune diseases: a systematic review and meta-analysis. Thorax 71:64\u201372. https:\/\/doi.org\/10.1136\/thoraxjnl-2015-207811","journal-title":"Thorax"},{"key":"5134_CR39","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1002\/art.10524","volume":"46","author":"MF Doran","year":"2002","unstructured":"Doran MF, Crowson CS, Pond GR, O\u2019Fallon WM, Gabriel SE (2002) Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 46:2287\u20132293. https:\/\/doi.org\/10.1002\/art.10524","journal-title":"Arthritis Rheum"},{"key":"5134_CR40","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1086\/587063","volume":"46","author":"T Gl\u00fcck","year":"2008","unstructured":"Gl\u00fcck T, M\u00fcller-Ladner U (2008) Vaccination in patients with chronic rheumatic or autoimmune diseases. Clin Infect Dis 46:1459\u20131465. https:\/\/doi.org\/10.1086\/587063","journal-title":"Clin Infect Dis"},{"key":"5134_CR41","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1086\/587063","volume":"36","author":"PL Meroni","year":"2018","unstructured":"Meroni PL, Zavaglia D, Girmenia C (2018) Vaccinations in adults with rheumatoid arthritis in an era of new disease-modifying anti-rheumatic drugs. Clin Exp Rheumatol 36:317\u2013328. https:\/\/doi.org\/10.1086\/587063","journal-title":"Clin Exp Rheumatol"},{"key":"5134_CR42","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1093\/rheumatology\/keu172","volume":"53","author":"A Souto","year":"2014","unstructured":"Souto A, Maneiro JR, Salgado E, Carmona L, Gomez-Reino JJ (2014) Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies. Rheumatology 53:1872\u20131885. https:\/\/doi.org\/10.1093\/rheumatology\/keu172","journal-title":"Rheumatology"},{"key":"5134_CR43","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1111\/ijd.12522","volume":"53","author":"N Duman","year":"2014","unstructured":"Duman N, Ersoy-Evans S, Karadag O, A\u015f\u00e7\u0131o\u011flu S, Sener B, Kiraz S et al (2014) Screening for latent tuberculosis infection in psoriasis and psoriatic arthritis patients in a tuberculosis-endemic country: a comparison of the QuantiFERON\u00ae-TB Gold In-Tube Test and tuberculin skin test. Int J Dermatol 53:1286\u20131292. https:\/\/doi.org\/10.1111\/ijd.12522","journal-title":"Int J Dermatol"},{"key":"5134_CR44","unstructured":"World Health Organization (2021) Global tuberculosis report 2021. https:\/\/apps.who.int\/iris\/handle\/10665\/346387 Accessed 3 April 2022"},{"key":"5134_CR45","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.autrev.2015.01.011","volume":"14","author":"F Cantini","year":"2015","unstructured":"Cantini F, Nannini C, Niccoli L, Iannone F, Delogu G, Garlaschi G et al (2015) Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice. Autoimmun Rev 14:503\u2013509. https:\/\/doi.org\/10.1016\/j.autrev.2015.01.011","journal-title":"Autoimmun Rev"},{"key":"5134_CR46","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1183\/09031936.00115110","volume":"37","author":"R Diel","year":"2011","unstructured":"Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, Kampmann B et al (2011) Interferon-\u03b3 release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 37:88\u201399. https:\/\/doi.org\/10.1183\/09031936.00115110","journal-title":"Eur Respir J"},{"key":"5134_CR47","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3109\/00365548.2014.938691","volume":"46","author":"HC Kim","year":"2014","unstructured":"Kim HC, Jo KW, Jung YJ, Yoo B, Lee CK, Kim YG et al (2014) Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay. Scand J Infect Dis 46:763\u2013769. https:\/\/doi.org\/10.3109\/00365548.2014.938691","journal-title":"Scand J Infect Dis"},{"key":"5134_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119260","volume":"10","author":"H Lee","year":"2015","unstructured":"Lee H, Park HY, Jeon K, Jeong BH, Hwang JW, Lee J et al (2015) QuantiFERON-TB Gold In-Tube assay for screening arthritis patients for latent tuberculosis infection before starting anti-tumor necrosis factor treatment. PLoS ONE 10:e0119260. https:\/\/doi.org\/10.1371\/journal.pone.0119260","journal-title":"PLoS ONE"},{"key":"5134_CR49","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1007\/s10067-017-3916-y","volume":"37","author":"A Soare","year":"2018","unstructured":"Soare A, Gheorghiu AM, Aram\u0103 V, Bumb\u0103cea D, Dobrot\u0103 R, Onea\u0163\u0103 R et al (2018) Risk of active tuberculosis in patients with inflammatory arthritis receiving TNF inhibitors: a look beyond the baseline tuberculosis screening protocol. Clin Rheumatol 37:2391\u20132397. https:\/\/doi.org\/10.1007\/s10067-017-3916-y","journal-title":"Clin Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05134-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-022-05134-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05134-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T02:03:19Z","timestamp":1662084199000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-022-05134-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":49,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["5134"],"URL":"https:\/\/doi.org\/10.1007\/s00296-022-05134-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-121794\/v1","asserted-by":"object"}]},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,29]]},"assertion":[{"value":"9 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was obtained from Hacettepe University Institutional Review Board (KA17\/058, May 2017) and Ministry of Health of Turkey (93189304-14.03.01, October 2017).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from each patient regarding the use of clinical data for research purposes. The study was in accordance with the 2013 amendment of the Helsinki declaration.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}